Gallegos Robert P, Nockel Pavel J, Rivard Andrew L, Bianco Richard W
University of Minnesota Department of Surgery, Experimental Surgical Services and the Lillehei Heart Institute, Minneapolis 55455, USA.
J Heart Valve Dis. 2005 May;14(3):423-32.
For over 30 years, animal models have remained a central critical component in the pre-clinical safety evaluation of prosthetic heart valves developed for use in humans. Though many advances have been made in valve design, no ideal replacement prosthesis has yet been developed. As a result, valve manufacturers continue to address issues relating to thrombogenicity, structural integrity, fluid dynamics and calcification in their designs. Many animal models have been developed to examine these issues, including dog, pig, calf and sheep, yet no standard model has been accepted. Recently, the International Standard Organization has provided guidelines in document 5840 to address cardiovascular implants. The aim of this report is to provide a summary of the current state of pre-clinical valve evaluation in animals. Changes in ISO 5840 will be addressed that have occurred between 1998 and the present date, and the role of current available animal models. The aim also is to provide rational guidance in the selection of appropriate animal models to match the purpose of valve implantation studies.
30多年来,动物模型一直是用于人类的人工心脏瓣膜临床前安全性评估的核心关键组成部分。尽管瓣膜设计取得了许多进展,但尚未开发出理想的替代假体。因此,瓣膜制造商在其设计中继续解决与血栓形成、结构完整性、流体动力学和钙化相关的问题。已经开发了许多动物模型来研究这些问题,包括狗、猪、小牛和绵羊,但尚未接受标准模型。最近,国际标准化组织在第5840号文件中提供了关于心血管植入物的指南。本报告的目的是总结动物临床前瓣膜评估的现状。将阐述1998年至今ISO 5840发生的变化以及当前可用动物模型的作用。其目的还在于为选择合适的动物模型以匹配瓣膜植入研究目的提供合理指导。